Research Team
Mihaela Popa
Mihaela Popa, DVM, COO, is the leading veterinarian of KinN Therapeutics. She has over 10 years of experience in the development of pre-clinical cancer models and multimodal imaging modalities.
Calum Leitch
Calum Leitch, M. Sc., PhD, Principal Scientist, has been working on the identification and repurposing of approved medicines for therapy development in Acute Myeloid Leukaemia. Leitch holds great expertise in pre-clinical research using PDX models as well as mass and flow cytometry.
Constance de Montlaur
Constance de Montlaur, M. Sc., PhD, laboratory engineer, has a PhD in physiology. She is involved in pre-clinical testing of new compounds.
Cara E. Wogsland
Cara Wogsland, PhD, Senior Researcher, is heading up mass cytometry (CyTOF) research at KinN Therapeutics. Her expertise lies in high-dimensional single-cell immunology of human tissues and mouse models of cancer. Wogsland has over a decade of experience in mass cytometry, spanning the full spectrum from panel design and tissue collection to advanced computational analysis.
Mireia Mayoral Safont
Mireia Mayoral Safont, B. Sc., laboratory engineer, has a bachelor degree in Biology, and three years’ experience from the pharmaceutical industry. In KinN Therapeutics, Safont plays a lead role in pre-clinical studies and has great experience in flow cytometry and PK/PD modeling.